Elevated interferon gamma signaling contributes to impaired regeneration in the aged liver

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 9, 2011, Pages 944-956

  Singh, Pallavi ^a,b   Goode, Triona ^b   Dean, Adam ^b   Awad, Samir S ^b   Darlington, Gretchen J ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Gamma interferon; Inflammation; Liver regeneration; Partial hepatectomy

Indexed keywords

MUS;

GAMMA INTERFERON; MESSENGER RNA; TOLL LIKE RECEPTOR;

AGING; ANIMAL; ARTICLE; C57BL MOUSE; CELL CYCLE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LIVER; LIVER REGENERATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL CYCLE; IMMUNITY, INNATE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER; LIVER REGENERATION; MACROPHAGES; MICE; MICE, INBRED C57BL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 80053527629     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr094     Document Type: Article

References (81)

1. Bucher NL, Swaffield MN, Ditroia JF. The influence of age upon the incorporation of thymidine-2-C14 into the DNA of regenerating rat liver. Cancer Res. 1964;24:509-512.
2. Stocker E, Heine WD. Regeneration of liver parenchyma under normal and pathological conditions. Beitr Pathol. 1971;144(4):400-408.
3. Tsukamoto I, Nakata R, Kojo S. Effect of ageing on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int. 1993;30(4):773-778. (Pubitemid 23250523)
4. Beyer HS, Sherman R, Zieve L. Aging is associated with reduced liver regeneration and diminished thymidine kinase mRNA content and enzyme activity in the rat. J Lab Clin Med. 1991;117(2):101-108.
5. Ikegami T, Nishizaki T, Yanaga K, et al. The impact of donor age on living donor liver transplantation. Transplantation. 2000;70(12):1703-1707. (Pubitemid 32064823)
6. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003;23(1):15-39. (Pubitemid 36268302)
7. Franceschi C, Bonafé M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254. (Pubitemid 30462008)
8. Cao SX, Dhahbi JM, Mote PL, Spindler SR. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA. 2001;98(19):10630-10635. (Pubitemid 32878672)
9. Amador-Noguez D, Yagi K, Venable S, Darlington G. Gene expression profile of long-lived Ames dwarf mice and Little mice. Aging Cell. 2004;3(6):423-441. (Pubitemid 40246712)
10. Haines DC, Chattopadhyay S, Ward JM. Pathology of aging B6;129 mice. Toxicol Pathol. 2001;29(6):653-661. (Pubitemid 34032643)
11. Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology. 2001;120(1):250-260. (Pubitemid 32061889)
12. Hines IN, Kremer M, Isayama F. Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology. 2007;46(1):229-241. (Pubitemid 47171940)
13. Vetelainen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245(1):44-50. (Pubitemid 46035434)
14. Francavilla A, Starzl TE, Barone M, et al. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology. 1991;14(1):140-143.
15. Singh P, Coskun ZZ, Goode C, Dean A, Thompson-Snipes L, Darlington G. Lymphoid neogenesis and immune infiltration in aged liver. Hepatology. 2008;47(5):1680-1690. (Pubitemid 351702750)
16. Takayama E, Seki S, Ohkawa T, et al. Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production. J Immunol. 2000;164(11):5652-5658. (Pubitemid 30389805)
17. Tura BJ, Bunyan KE, Harrison DJ. The effect of IFN-gamma on the hepatocyte: cell cycle and apoptosis. Int J Exp Pathol. 2001;82(6):317-326. (Pubitemid 34063030)
18. Sun R, Park O, Horiguchi N, et al. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice. Hepatology. 2006;44(4):955-966. (Pubitemid 46489560)
19. Kano A, Haruyama T, Akaike T, Watanabe Y. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun. 1999;257(3):672-677. (Pubitemid 29301501)
20. Kano A, Watanabe Y, Takeda N, Aizawa S, Akaike T. Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. J Biochem. 1997;121(4):677-683. (Pubitemid 27170850)
21. Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology. 2005;41(4):906-915. (Pubitemid 40462953)
22. Lee HJ, Oh YK, Rhee M, et al. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J Mol Biol. 2007;369(4):967-984. (Pubitemid 46754063)
23. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA. 2003;100(1):143-148. (Pubitemid 36078042)
24. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology. 2004;127(5):1525-1539. (Pubitemid 39457777)
25. Higgins GM, Anderson RM. Experimental pathology of the liver. Arch Pathol. 1931;12:186-202.
26. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA. 1998;95(26):15623-15628. (Pubitemid 29018750)
27. Zocco MA, Carloni E, Pescatori M, et al. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma. Dig Liver Dis. 2006;38(8):563-577. (Pubitemid 44356255)
28. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749-795.
29. Yazici MK, Anil Yaǧcioǧlu AE, Ertuǧrul A, et al. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch Gerontol Geriatr. 2006;42(1):35-45.
30. Blouin K, Desprès JP, Couillard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism. 2005;54(8):1034-1040. (Pubitemid 41033104)
31. Grayson BL, Wang L, Aune TM. Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. Genes Immun. doi:10.1038/gene.2011.13
32. González AS, Guerrero DB, Soto MB, Dìaz SP, Martinez-Olmos M, Vidal O. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr. 2006;60(6):802-809. (Pubitemid 43842236)
33. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143(10):722-728.
34. Einstein FH, Huffman DM, Fishman S, et al. Aging per se increases the susceptibility to free fatty acid-induced insulin resistance. J Gerontol A Biol Sci Med Sci. 2010;65(8):800-808.
35. Lebel M, Picard F, Ferland G, Gaudreau P. Drugs, nutrients, and phytoactive principles improving the health span of rodent models of human age-related diseases. J Gerontol A Biol Sci Med Sci. doi:10.1093/gerona/glr038
36. Labbè A, Garand C, Cogger VC, et al. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome. J Gerontol A Biol Sci Med Sci. 2011;66(3):264-278.
37. Allman M, Gaskin L, Rivera CA. CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing. J Gastroenterol Hepatol. 2010;25(3):635-643.
38. DeAngelis RA, Markiewski MM, Taub R, Lambris JD. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology. 2005;42(5):1148-1157. (Pubitemid 43112682)
39. Yamauchi H, Uetsuka K, Okada T, Nakayama H, Doi K. Impaired liver regeneration after partial hepatectomy in db/db mice. Exp Toxicol Pathol. 2003;54(4):281-286. (Pubitemid 36362232)
40. Popper H. Aging and the liver. Prog Liver Dis. 1986;8:659-683.
41. Shima A, Sugahara T. Age-dependent ploidy class changes in mouse hepatocyte nuclei as revealed by Feulgen-DNA cytofluorometry. Exp Gerontol. 1976;11(5-6):193-203. (Pubitemid 8012504)
42. Enesco HE, Samborsky J. Liver polyploidy: influence of age and of dietary restriction. Exp Gerontol. 1983;18(1):79-87. (Pubitemid 13099364)
43. Gerlyng P, Abyholm A, Grotmol T, et al. Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif. 1993;26(6):557-565. (Pubitemid 24012231)
44. Gerlyng P, Grotmol T, Seglen PO. Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation. Carcinogenesis. 1994;15(2):371-379. (Pubitemid 24121677)
45. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet. 1992;8(6):193-197.
46. Lundblad V, Blackburn EH. An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell. 1993;73(2):347-360. (Pubitemid 23123312)
47. Takubo K, Kaminishi M. [Diseases of the digestive tract and telomere lengths: significance and problems of telomere measurement]. Nippon Shokakibyo Gakkai Zasshi. 2001;98(2):144-150. (Pubitemid 32175867)
48. Takubo K, Nakamura K, Izumiyama N, et al. Telomere shortening with aging in human liver. J Gerontol A Biol Sci Med Sci. 2000;55(11):B533-B536. (Pubitemid 32010303)
49. Aikata H, Takaishi H, Kawakami Y, et al. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res. 2000;256(2):578-582. (Pubitemid 30244216)
50. Krupczak-Hollis K, Wang X, Dennewitz MB, Costa RH. Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology. 2003;38(6):1552-1562. (Pubitemid 37466981)
51. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-764. (Pubitemid 40292986)
52. Tsukahara A, Seki S, Iiai T, et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology. 1997;26(2):301-309. (Pubitemid 27328305)
53. Ohteki T, Abo T, Seki S, et al. Predominant appearance of gamma/delta T lymphocytes in the liver of mice after birth. Eur J Immunol. 1991;21(7):1733-1740.
54. Ohteki T, Okuyama R, Seki S, et al. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol. 1992;149(5):1562-1570.
55. Gomez CR, Acuna-Castillo C, Pèrez C, et al. Diminished acute phase response and increased hepatic inflammation of aged rats in response to intraperitoneal injection of lipopolysaccharide. J Gerontol A Biol Sci Med Sci. 2008;63(12):1299-1306.
56. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology. 1990;11(6):916-922. (Pubitemid 20221025)
57. Seki E, Tsutsui H, Iimuro Y, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology. 2005;41(3):443-450. (Pubitemid 40289490)
58. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274(5291):1379-1383. (Pubitemid 26391463)
59. Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med. 2003;198(6):913-923. (Pubitemid 37152928)
60. Chen GW, Zhang MZ, Zhao LF, Xu CS. Expression patterns and action analysis of genes associated with physiological responses during rat liver regeneration: innate immune response. World J Gastroenterol. 2006;12(48):7852-7858.
61. Wüstefeld T, Rakemann T, Kubicka S, Manns MP, Trautwein C. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology. 2000;32(3):514-522.
62. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002;161(1):155-161. (Pubitemid 34760781)
63. Mohammed FF, Smookler DS, Taylor SE, et al. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004;36(9):969-977. (Pubitemid 39167493)
64. Enami Y, Kato H, Murakami M, et al. Anti-transforming growth factor-beta1 antibody transiently enhances DNA synthesis during liver regeneration after partial hepatectomy in rats. J Hepatobiliary Pancreat Surg. 2001;8(3):250-258. (Pubitemid 33690546)
65. Romero-Gallo J, Sozmen EG, Chytil A, et al. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene. 2005;24(18):3028-3041. (Pubitemid 40675534)
66. Sun L, Sadighi Akha AA, Miller RA, Harper JM. Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. J Gerontol A Biol Sci Med Sci. 2009;64(7):711-722.
67. Bokov AF, Lindsey ML, Khodr C, Sabia MR, Richardson A. Long-lived ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci. 2009;64(8):819-827.
68. Chou MW, Shaddock JG, Kong J, Hart RW, Casciano DA. Effect of dietary restriction on partial hepatectomy-induced liver regeneration of aged F344 rats. Cancer Lett. 1995;91(2):191-197.
69. Rai RM, Loffreda S, Karp CL, Yang SQ, Lin HZ, Diehl AM. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology. 1997;25(4):889-895. (Pubitemid 27157130)
70. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev. 2000;174:135-149. (Pubitemid 30201385)
71. Huang W, Dong Z, Wei H, Ding C, Sun R, Tian Z. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice. Liver Int. 2006;26(3):339-345. (Pubitemid 43349325)
72. Ito H, Ando K, Nakayama T, et al. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology. 2003;38(5):1116-1124. (Pubitemid 37314820)
73. Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg. 1990;211(2):141-145. (Pubitemid 20063200)
74. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229(2):210-215. (Pubitemid 30191794)
75. Eguchi H, Umeshita K, Sakon M, et al. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure. Dig Dis Sci. 2000;45(7):1383-1388. (Pubitemid 30636514)
76. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2(3):292-298. (Pubitemid 128409616)
77. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis. 2007;27(2):173-193. (Pubitemid 46871663)
78. Soejima Y, Shimada M, Suehiro T, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation. 2003;76(2):344-348. (Pubitemid 36927996)
79. Sawabe M, Arai T, Esaki Y, Fukazawa T, Takubo K, Hirokawa K. Fulminant hepatic failure in the elderly: a clinicopathological study of autopsy cases aged over 65 years. Pathol Int. 2000;50(2):p. 98-105. (Pubitemid 30253278)
80. Ohnishi H, Muto Y, Maeda T, et al. Natural killer cell may impair liver regeneration in fulminant hepatic failure. Gastroenterol Jpn. 1993;28(suppl 4):40-44; discussion 53-56. (Pubitemid 23135818)
81. Kimura K, Ando K, Tomita E, et al. Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fulminant hepatitis. J Hepatol. 1999;31(4):579-583. (Pubitemid 29487676)